Inhibitors of growth factor activation as new adjunct chemotherapy for cancer
September 27th, 2016 – Jim Janetka, PhD, Associate Professor, Department of Biochemistry and Molecular Biophysics, received a new two year grant award from the Alvin J. Siteman Cancer Research Fund for his research entitled “Inhibitors of growth factor activation as new adjunct chemotherapy for cancer”.
More information here: “Siteman fund grants $300,000 for unique approaches to fighting cancer”

Mr. Welty received his B.S., double majoring in chemistry and biochemistry, from the University of Minnesota Duluth. During that time, he began doing research studying the effects of molecular crowding on diffusion using fluorescence correlation spectroscopy (FCS).
Ms. Hailemariam received her undergraduate degree in Biology from Shaw University in Raleigh, North Carolina. She joined the Division of Biological and Biomedical Sciences at Washington University in St. Louis in 2012 as part of the Molecular Cell Biology program. 